News

Liver transplantation is the sole curative option for HCC, but new therapies prompt reconsideration of transplant timing and ...
LIVER CANCER, the third leading cause of cancer-related deaths globally, is primarily attributed to hepatocellular carcinoma ...
There are multiple techniques for performing liver biopsies via a celiotomy. Ultimately, the choice of technique is at the ...
Hepatocellular carcinoma (HCC), the most common form of liver cancer, continues to pose a significant global health challenge ...
A new study reveals how a critical imbalance in bile acids—the substances made by the liver that help digest fats—can trigger ...
White patients had an increased burden of advanced liver fibrosis vs Black patients, despite comparable levels of inflammation.
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...
The Risk Estimation of Tumor REcurrence After Transplant score accurately predicted hepatocellular carcinoma recurrence after liver transplantation.